SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-19-004728
Filing Date
2019-04-24
Accepted
2019-04-24 15:15:16
Documents
2
Period of Report
2019-04-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT azrx8k_apr2019.htm 8-K 31885
2 PRESS RELEASE ex99-1.htm EX-99.1 16586
  Complete submission text file 0001654954-19-004728.txt   49644
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-37853 | Film No.: 19763718
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1